Sort
21,281 grants matching “influenza”
ZFAND6 regulation of innate antiviral immunity
$237,480Edward W Harhaj · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2020 · AI
1 and 2D IR structural analyses of Influenza M2 channel
$237,413Martin T Zanni · University Of Wisconsin-Madison · R21 · FY2006 · AI
Predicting Protein Evolution with Phage Escape
$237,375Tobin J Dickerson · Scripps Research Institute, The · R21 · FY2010 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE
$237,368Wistar Institute · R01 · FY2000 · AI
Measuring Influenza and H1N1 vaccine responses in immunodeficient patients
$237,311Paul Joseph Utz · Stanford University · U19 · FY2012 · AI
Identification of small molecule furin-like protease inhibitors
$237,248Julia Coppola · Boise Technology, Inc. · R43 · FY2009 · GM
Mechanism of Synaptic SNARE Assembly
$237,231Yeon-Kyun Shin · Iowa State University · R01 · FY2006 · GM
Single-cell phospho-protein signaling analysis of the response to influenza vacci
$237,202Garry P Nolan · Stanford University · U19 · FY2013 · AI
Vaccines as drivers of disease emergence: transmission ecology and virulence evol
$237,181Andrew F. Read · Pennsylvania State University, The · R01 · FY2016 · GM
T cell/astrocyte fusions as a novel form of trained immunity to infection
$237,162E. Ashley Moseman · Duke University · R21 · FY2023 · NS
Polymicrobial Interactions in the Lung
$237,048Jennifer Melinda Bomberger · University Of Pittsburgh At Pittsburgh · R00 · FY2013 · HL
Promotion of pneumococcal adherence by viral infection
$237,000Albany Medical College · R21 · FY2004 · AI
Transcriptional control in innate lymphoid type II cells
$237,000Dorina Avram · Albany Medical College · R21 · FY2014 · AI
AMPAkines for Novel Opioid Use Disorder Pharmacotherapy
$237,000Noelle C Anastasio · University Of Texas Med Br Galveston · U18 · FY2020 · DA
Adipokines in Pulmonary Viral Infection
$237,000Thomas J Braciale · University Of Virginia · R21 · FY2015 · AI
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
$237,000Balaji Manicassamy · University Of Chicago · R21 · FY2015 · AI
Promotion of pneumococcal adherence by viral infection
$237,000Albany Medical College · R21 · FY2003 · AI
Design of immunogens for elicitation of neutralizing antibody responses against Zika virus
$237,000Ivelin Georgiev · Vanderbilt University Medical Center · R21 · FY2019 · AI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program
$236,944Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · D43 · FY2022 · TW
Inhaled Brevetoxins: Health Effects and Mechanisms
$236,919Janet M. Benson · University Of North Carolina Wilmington · P01 · FY2007 · ES
Identification and Hit-to-Lead Development of Influenza A Virus Inhibitors
$236,906Richard K. Plemper · Georgia State University · R21 · FY2015 · AI
Development of a broadly neutralizing influenza virus vaccine
$236,875Anette Schneemann · Scripps Research Institute, The · R21 · FY2011 · AI
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity
$236,858Thomas Stoeger · Northwestern University · R00 · FY2025 · AG
EVALUATING USE A RAPID TESTING FOR INFLUENZA IN OUTPATIENT MEDICA SETTING
$236,836Nancy Jean Kupka · Joint Commission · U47 · FY2009 · CI
Viral impact on autoimmune T cells
$236,718Sarah L. Gaffen · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI